ResMed, Inc. (RMD) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $188.45 -0.1%
EPS Growth %: +13.3%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +13.3%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.33, $0.02 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $314.8 million versus the consensus estimate of $326.32 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- This digital health stock is ready to re-rate higher: Goldman
- Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
- Vince Holding (VNCE) Tops Q1 EPS by 21c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
